应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09606 映恩生物-B
未开盘 03-09 16:08:19
313.000
-2.600
-0.82%
最高
320.000
最低
298.200
成交量
72.45万
今开
309.000
昨收
315.600
日振幅
6.91%
总市值
282.13亿
流通市值
282.13亿
总股本
9,014万
成交额
2.24亿
换手率
0.80%
流通股本
9,014万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 映恩生物-B 03月09日卖空量成交8.29万股,卖空比例为11.44%
市场透视 · 03-09 16:30
每日卖空追踪 | 映恩生物-B 03月09日卖空量成交8.29万股,卖空比例为11.44%
映恩生物-B盘中异动 早盘股价大跌5.01%
市场透视 · 03-09 09:31
映恩生物-B盘中异动 早盘股价大跌5.01%
【国投证券 | 医药】新药周观点:映恩B7H3 ADC展现mCRPC领域BIC潜力,后续多个二代IO+ADC数据读出值得期待
国投证券医药研究 · 03-08 20:28
【国投证券 | 医药】新药周观点:映恩B7H3 ADC展现mCRPC领域BIC潜力,后续多个二代IO+ADC数据读出值得期待
港股通3月调整前瞻:44只港股有望纳入 英硅智能(03696)、京东工业(07618)等在列
智通财经 · 03-06
港股通3月调整前瞻:44只港股有望纳入 英硅智能(03696)、京东工业(07618)等在列
创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情
金吾财讯 · 03-06
创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情
每日卖空追踪 | 映恩生物-B 03月05日卖空量成交3.97万股,卖空比例为4.56%
市场透视 · 03-05
每日卖空追踪 | 映恩生物-B 03月05日卖空量成交3.97万股,卖空比例为4.56%
映恩生物-B盘中异动 早盘急速拉升5.05%报299.400港元
市场透视 · 03-05
映恩生物-B盘中异动 早盘急速拉升5.05%报299.400港元
映恩生物-B03月03日主力净流出191.1万元 散户资金买入
市场透视 · 03-03
映恩生物-B03月03日主力净流出191.1万元 散户资金买入
映恩生物(09606)2026年2月月报:股本维持不变
公告速递 · 03-02
映恩生物(09606)2026年2月月报:股本维持不变
每日卖空追踪 | 映恩生物-B 03月02日卖空量成交4.28万股,卖空比例为4.15%
市场透视 · 03-02
每日卖空追踪 | 映恩生物-B 03月02日卖空量成交4.28万股,卖空比例为4.15%
每日卖空追踪 | 映恩生物-B 02月27日卖空量成交2.66万股,卖空比例为5.81%
市场透视 · 02-27
每日卖空追踪 | 映恩生物-B 02月27日卖空量成交2.66万股,卖空比例为5.81%
每日卖空追踪 | 映恩生物-B 02月26日卖空量成交5800股,卖空比例为0.64%
市场透视 · 02-26
每日卖空追踪 | 映恩生物-B 02月26日卖空量成交5800股,卖空比例为0.64%
映恩生物-B盘中异动 下午盘急速下挫5.00%报319.200港元
市场透视 · 02-26
映恩生物-B盘中异动 下午盘急速下挫5.00%报319.200港元
映恩生物-B(09606):核心产品DB-1311/BNT324于2026年美国临床肿瘤学会泌尿生殖系统癌症研讨会上公布的研究结果
智通财经网 · 02-24
映恩生物-B(09606):核心产品DB-1311/BNT324于2026年美国临床肿瘤学会泌尿生殖系统癌症研讨会上公布的研究结果
每日卖空追踪 | 映恩生物-B 02月23日卖空量成交3000股,卖空比例为2.04%
市场透视 · 02-23
每日卖空追踪 | 映恩生物-B 02月23日卖空量成交3000股,卖空比例为2.04%
蛋白降解(TPD):26年看自免管线临床突破
华福证券 · 02-23
蛋白降解(TPD):26年看自免管线临床突破
每日卖空追踪 | 映恩生物-B 02月20日卖空量成交2.37万股,卖空比例为11.26%
市场透视 · 02-20
每日卖空追踪 | 映恩生物-B 02月20日卖空量成交2.37万股,卖空比例为11.26%
映恩生物-B02月20日获主力加仓93.2万元
市场透视 · 02-20
映恩生物-B02月20日获主力加仓93.2万元
每日卖空追踪 | 映恩生物-B 02月16日卖空量成交1.03万股,卖空比例为25.25%
市场透视 · 02-16
每日卖空追踪 | 映恩生物-B 02月16日卖空量成交1.03万股,卖空比例为25.25%
每日卖空追踪 | 映恩生物-B 02月13日卖空量成交4.54万股,卖空比例为11.3%
市场透视 · 02-13
每日卖空追踪 | 映恩生物-B 02月13日卖空量成交4.54万股,卖空比例为11.3%
暂无数据
公司概况
公司名称:
映恩生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
映恩生物是一家主要从事临床阶段生物制药的投资控股公司。该公司致力于为癌症和自身免疫性疾病等患者研发抗体偶联药物(ADC)创新药物。该公司的主要候选药物产品包括DB-1303/BNT323、DB-1311/BNT324、DB-1310、DB-1305/BNT325、DB-1419和DB-2304。该公司的产品主要用于靶向治疗子宫内膜癌(EC)、乳腺癌(BC)、小细胞肺癌(SCLC)、去势抵抗性前列腺癌(CRPC)、食管鳞状细胞癌(ESCC)及头颈部鳞状细胞癌(HNSCC)。该公司主要在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"映恩生物-B","latestPrice":313,"timestamp":1773043699008,"preClose":315.6,"halted":0,"volume":724487,"delay":0,"changeRate":-0.008238276299112873,"floatShares":90137700,"shares":90137700,"eps":-131.30424,"marketStatus":"未开盘","change":-2.6,"latestTime":"03-09 16:08:19","open":309,"high":320,"low":298.2,"amount":224265574,"amplitude":0.069075,"askPrice":313,"askSize":4700,"bidPrice":312.8,"bidSize":3400,"shortable":3,"etf":0,"ttmEps":-34.438,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773106200000},"marketStatusCode":0,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":315.6,"openAndCloseTimeList":[[1773019800000,1773028800000],[1773032400000,1773043200000]],"volumeRatio":0.60666,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09606/tweets","defaultTab":"tweets","newsList":[{"id":"2618642772","title":"每日卖空追踪 | 映恩生物-B 03月09日卖空量成交8.29万股,卖空比例为11.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618642772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618642772?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045041,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间03月09日,跌0.82%,卖空量成交8.29万股,较上一交易日减少74.24%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163614a6b1c9dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163614a6b1c9dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","HK0000500386.USD","09606","HK0000252160.HKD","HK0000252152.HKD","BK1161"],"gpt_icon":0},{"id":"2618642703","title":"映恩生物-B盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618642703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618642703?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:31","pubTimestamp":1773019911,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时31分,映恩生物-B股票出现异动,股价大幅下挫5.01%。截至发稿,该股报299.800港元/股,成交量3.51万股,换手率0.04%,振幅3.23%。映恩生物-B股票所在的生物技术行业中,整体跌幅为2.03%。其相关个股中,科济药业-B、维立志博-B、派格生物医药-B涨幅较大,振幅较大的相关个股有科济药业-B、药捷安康-B、派格生物医药-B,振幅分别为16.47%、12.39%、12.31%。映恩生物-B公司简介:映恩生物是一家主要从事临床阶段生物制药的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909315197aa99b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909315197aa99b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","LU2543165471.USD","HK0000252160.HKD","BK1161","HK0000252152.HKD","09606"],"gpt_icon":0},{"id":"2618939926","title":"【国投证券 | 医药】新药周观点:映恩B7H3 ADC展现mCRPC领域BIC潜力,后续多个二代IO+ADC数据读出值得期待","url":"https://stock-news.laohu8.com/highlight/detail?id=2618939926","media":"国投证券医药研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618939926?lang=zh_cn&edition=full","pubTime":"2026-03-08 20:28","pubTimestamp":1772972929,"startTime":"0","endTime":"0","summary":"截至2025年12月29日,共纳入146例既往接受过多线治疗的mCRPC患者,中位年龄为70岁,中位既往治疗线数为4线。这是B7H3 ADC类药物,首次在Lu 177经治的mCRPC患者中展现出优异的持久疗效。中国生物制药有权获得最高15.3亿美元的付款,其中包括1.35亿美元的首付款以及里程碑付款。德琪医药将获得总计8,000万美元的首付款及近期里程碑付款,并有望在未来获得","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260308203514a4582528&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260308203514a4582528&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","HK0000252152.HKD","BK1574","BK1515","BK1161","HK0000252160.HKD","HK0000500386.USD","09939","09606"],"gpt_icon":0},{"id":"2617502435","title":"港股通3月调整前瞻:44只港股有望纳入 英硅智能(03696)、京东工业(07618)等在列","url":"https://stock-news.laohu8.com/highlight/detail?id=2617502435","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617502435?lang=zh_cn&edition=full","pubTime":"2026-03-06 13:56","pubTimestamp":1772776602,"startTime":"0","endTime":"0","summary":"考虑恒生综指成分股的要求,再考虑纳入港股通的额外标准,此次或共有44只股票符合纳入港股通标准,包括:东亚银行、周大福创建、滴普科技、乐舒适、创新实业、奇富科技-S、京东工业、英硅智能、健康160、中慧生物-B、宝济药业-B、派格生物医药-B、劲方医药-B、轩竹生物-B等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02698","BKEAY","02007","02788","03887","BK1141","01384","09606","BK1207","BK1175","BK1572","00023","00659","02617","03696","02656","BK1230","03660","CTRYY","00863","NWSGY","BK1124","BK1117","BK1601","02609","BK1160","BK4585","BK1170","SG9999003461.SGD","BK4588","QFIN","BK1231","07618"],"gpt_icon":0},{"id":"2617066845","title":"创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617066845","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617066845?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:41","pubTimestamp":1772764875,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药板块强势,三生制药 涨9.83%,基石药业-B涨6.84%,荣昌生物涨6.31%,映恩生物-B涨5.98%,四环医药涨5.76%,恒瑞医药涨5.77%,君圣泰医药-B涨5.58%,康诺亚-B涨5.31%,复宏汉霖涨5.02%。交银国际表示,本周各公司业绩预告陆续发布,该机构建议持续关注财务表现超预期、盈利路径清晰的公司,其业绩兑现有望催化板块行情。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976042","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","LU2328871848.SGD","BK1583","09606","01276","00460","HK0000252160.HKD","HK0000165453.HKD","BK1515","HK0000320223.HKD","LU0359201612.USD","LU1023057109.AUD","BK1593","HK0000320264.USD","LU1969619763.USD","LU0359202008.SGD","02616","BK1587","BK1600","BK1574","06978","09995","LU2543165471.USD","LU0359201885.HKD","02696","BK1191","159992","HK0000500386.USD","02162","HK0000306685.HKD","HK0000306701.USD","BK1161","HK0000252152.HKD","02511"],"gpt_icon":0},{"id":"2617552012","title":"每日卖空追踪 | 映恩生物-B 03月05日卖空量成交3.97万股,卖空比例为4.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617552012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617552012?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699442,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间03月05日,涨2.18%,卖空量成交3.97万股,较上一交易日减少74.12%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163604a6a5db84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163604a6a5db84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD","BK1161","09606"],"gpt_icon":0},{"id":"2617520171","title":"映恩生物-B盘中异动 早盘急速拉升5.05%报299.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617520171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617520171?lang=zh_cn&edition=full","pubTime":"2026-03-05 10:11","pubTimestamp":1772676664,"startTime":"0","endTime":"0","summary":"2026年03月05日早盘10时11分,映恩生物-B股票出现波动,股价急速拉升5.05%。截至发稿,该股报299.400港元/股,成交量12.2539万股,换手率0.14%,振幅2.67%。资金方面,该股资金流入1664.75万港元,流出1395.48万港元。机构评级方面,在所有6家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。映恩生物-B股票所在的生物技术行业中,整体涨幅为2.50%。映恩生物-B公司简介:映恩生物是一家主要从事临床阶段生物制药的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305101104a6a46962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305101104a6a46962&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","BK1161","HK0000252152.HKD","09606","LU2543165471.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2616032538","title":"映恩生物-B03月03日主力净流出191.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616032538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616032538?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:15","pubTimestamp":1772525707,"startTime":"0","endTime":"0","summary":"03月03日, 映恩生物-B股价跌1.14%,报收295.60元,成交金额2.4亿元,换手率0.92%,振幅6.02%,量比1.11。映恩生物-B今日主力资金净流出191.1万元,上一交易日主力净流入1084.8万元。该股近5个交易日下跌12.78%,主力资金累计净流入2283.0万元;近20日主力资金累计净流入5066.4万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303161518a69c948a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303161518a69c948a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","09606","HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","BK1161"],"gpt_icon":0},{"id":"1140617241","title":"映恩生物(09606)2026年2月月报:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1140617241","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140617241?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:42","pubTimestamp":1772440963,"startTime":"0","endTime":"0","summary":"映恩生物于2026年3月2日披露的2026年2月证券变动月报显示,公司股本结构稳定,未发现新增发行或购回及注销情况。报告期为截至2026年2月28日。公司普通股法定注册股本仍为200,000,000股,面值0.0001美元,注册股本总额20,000美元。根据公告,映恩生物在期内并无新增股份发行、库藏或注销操作。另“2025年股份计划”亦未发生股份发行或转让。截至2026年2月28日,公司确认符合香港联交所对最低公众持股量的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"gpt_icon":0},{"id":"2616436811","title":"每日卖空追踪 | 映恩生物-B 03月02日卖空量成交4.28万股,卖空比例为4.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616436811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616436811?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440244,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间03月02日,跌5.08%,卖空量成交4.28万股,较上一交易日减少15.25%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163650a730ca56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163650a730ca56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","BK1161","HK0000252160.HKD","HK0000252152.HKD","LU2543165471.USD","09606"],"gpt_icon":0},{"id":"2614025890","title":"每日卖空追踪 | 映恩生物-B 02月27日卖空量成交2.66万股,卖空比例为5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614025890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614025890?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181043,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间02月27日,跌0.57%,卖空量成交2.66万股,较上一交易日减少64.95%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163618a4367acc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163618a4367acc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","HK0000500386.USD","HK0000252160.HKD","BK1161","HK0000252152.HKD","LU2543165471.USD"],"gpt_icon":0},{"id":"2614005851","title":"每日卖空追踪 | 映恩生物-B 02月26日卖空量成交5800股,卖空比例为0.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614005851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614005851?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:30","pubTimestamp":1772094641,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间02月26日,跌5.71%,卖空量成交5800股,较上一交易日减少78.75%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163621a4cab791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163621a4cab791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000252160.HKD","LU2543165471.USD","09606","HK0000500386.USD","HK0000252152.HKD"],"gpt_icon":0},{"id":"2614005887","title":"映恩生物-B盘中异动 下午盘急速下挫5.00%报319.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614005887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614005887?lang=zh_cn&edition=full","pubTime":"2026-02-26 14:41","pubTimestamp":1772088087,"startTime":"0","endTime":"0","summary":"2026年02月26日下午盘14时41分,映恩生物-B股票出现波动,股价快速下挫5.00%。截至发稿,该股报319.200港元/股,成交量63.0832万股,换手率0.70%,振幅7.20%。资金方面,该股资金流入7019.65万港元,流出1.05421亿港元。映恩生物-B股票所在的生物技术行业中,整体跌幅为4.79%。其相关个股中,思路迪医药股份、百奥赛图-B、药捷安康-B涨幅较大,振幅较大的相关个股有三叶草生物-B、百奥赛图-B、药捷安康-B,振幅分别为11.96%、11.38%、9.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226144127a4ca443e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226144127a4ca443e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09606","HK0000252160.HKD","LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD"],"gpt_icon":0},{"id":"2613758759","title":"映恩生物-B(09606):核心产品DB-1311/BNT324于2026年美国临床肿瘤学会泌尿生殖系统癌症研讨会上公布的研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2613758759","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613758759?lang=zh_cn&edition=full","pubTime":"2026-02-24 06:07","pubTimestamp":1771884462,"startTime":"0","endTime":"0","summary":"映恩生物-B(09606)发布公告,于2026年2月26日至2月28日在美国旧金山举行的2026年美国临床肿瘤学会(ASCO)泌尿生殖系统 \n(GU)癌症研讨会上,本公司将展示DB-1311/BNT324(一种在研B7H3抗体偶联药物(ADC))在治疗既往接受过深度治疗的转移性去势抵抗性前列腺癌(mCRPC)患者(包括根据既往接受镥177 \n(177Lu)-PSMA-617 (Lu 177)治疗情况进行的分析)的 \n1/2期DB-1311-O-1001研究(NCT05914116)的最新疗效及安全性结果","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_40.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_40.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["HK0000500386.USD","BK4585","BK4552","LU2543165471.USD","BK1161","BK4588","09606","HK0000252160.HKD","BK4566","BK4118","DB","HK0000252152.HKD"],"gpt_icon":0},{"id":"2613811297","title":"每日卖空追踪 | 映恩生物-B 02月23日卖空量成交3000股,卖空比例为2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613811297","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613811297?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835442,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间02月23日,跌0.06%,卖空量成交3000股,较上一交易日减少92.97%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163549a71565ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163549a71565ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","HK0000252160.HKD","LU2543165471.USD","BK1161","09606","HK0000252152.HKD"],"gpt_icon":0},{"id":"2613781173","title":"蛋白降解(TPD):26年看自免管线临床突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2613781173","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613781173?lang=zh_cn&edition=full","pubTime":"2026-02-23 00:00","pubTimestamp":1771776000,"startTime":"0","endTime":"0","summary":"本周涨幅前五的个股为:振德医疗、欧林生物、美好医疗、万泽股份、博拓生物TPD 赛道研发火热,26 年重点关注自免管线临床进展。蛋白降解技术在自身免疫疾病进展迅速,STAT6、IRAK4、IRF5、VAV1、NLRP3、NEK7 等热门小分子靶点备受关注。2026 年开始,众多自免TPD 靶点将迎来数据读出,或进入到临床关键性阶段,值得重点关注。国内公司中,苑东生物、诺诚健华均有VAV1 分子胶产品布局,海思科、先声药业均有STAT6 靶点布局,百济神州亦有IRAK4 靶点布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223171634a7157e24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223171634a7157e24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","09606","HK0000252152.HKD","HK0000500386.USD","LU2543165471.USD","BK1515","LU1303224171.USD","LU1719994722.HKD","BK1161","LU1770034418.SGD","09939","BK1588","LU0588546209.SGD","BK1500","LU1251922891.USD","LU0307460666.USD","HK0000252160.HKD","06160","02096","BK1583","LU1969619763.USD","BK1574"],"gpt_icon":0},{"id":"2612504052","title":"每日卖空追踪 | 映恩生物-B 02月20日卖空量成交2.37万股,卖空比例为11.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612504052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612504052?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576240,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间02月20日,涨1.75%,卖空量成交2.37万股,较上一交易日增加130.1%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163542a4b5e9dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163542a4b5e9dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000252152.HKD","09606","LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2612504762","title":"映恩生物-B02月20日获主力加仓93.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612504762","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612504762?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:15","pubTimestamp":1771575329,"startTime":"0","endTime":"0","summary":"02月20日, 映恩生物-B股价涨1.75%,报收349.00元,成交金额7307.8万元,换手率0.23%,振幅2.39%,量比0.41。映恩生物-B今日主力资金净流入93.2万元,连续6日净流入,上一交易日主力净流入627.2万元。该股近5个交易日上涨5.49%,主力资金累计净流入3294.6万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1029.5万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161642a70cc2e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161642a70cc2e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","09606","BK1161","HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD"],"gpt_icon":0},{"id":"2611483058","title":"每日卖空追踪 | 映恩生物-B 02月16日卖空量成交1.03万股,卖空比例为25.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611483058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611483058?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230637,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间02月16日,涨2.08%,卖空量成交1.03万股,较上一交易日减少85.51%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163518a700e063&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163518a700e063&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","HK0000252160.HKD","HK0000500386.USD","BK1161","HK0000252152.HKD","LU2543165471.USD"],"gpt_icon":0},{"id":"2611198443","title":"每日卖空追踪 | 映恩生物-B 02月13日卖空量成交4.54万股,卖空比例为11.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611198443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611198443?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:30","pubTimestamp":1770971443,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间02月13日,涨2.75%,卖空量成交4.54万股,较上一交易日增加30.46%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163624a49ffbda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163624a49ffbda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD","HK0000500386.USD","BK1161","09606"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dualitybiologics.com","stockEarnings":[{"period":"1week","weight":0.0468},{"period":"1month","weight":-0.0063},{"period":"3month","weight":0.0084},{"period":"6month","weight":-0.2771},{"period":"1year","weight":2.3087},{"period":"ytd","weight":0.0496}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":-0.0434},{"period":"3month","weight":-0.001},{"period":"6month","weight":-0.0302},{"period":"1year","weight":0.0486},{"period":"ytd","weight":-0.0087}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"映恩生物是一家主要从事临床阶段生物制药的投资控股公司。该公司致力于为癌症和自身免疫性疾病等患者研发抗体偶联药物(ADC)创新药物。该公司的主要候选药物产品包括DB-1303/BNT323、DB-1311/BNT324、DB-1310、DB-1305/BNT325、DB-1419和DB-2304。该公司的产品主要用于靶向治疗子宫内膜癌(EC)、乳腺癌(BC)、小细胞肺癌(SCLC)、去势抵抗性前列腺癌(CRPC)、食管鳞状细胞癌(ESCC)及头颈部鳞状细胞癌(HNSCC)。该公司主要在国内和国外市场开展业务。","exchange":"SEHK","name":"映恩生物-B","nameEN":"DUALITYBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供映恩生物-B(09606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"映恩生物-B,09606,映恩生物-B股票,映恩生物-B股票老虎,映恩生物-B股票老虎国际,映恩生物-B行情,映恩生物-B股票行情,映恩生物-B股价,映恩生物-B股市,映恩生物-B股票价格,映恩生物-B股票交易,映恩生物-B股票购买,映恩生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供映恩生物-B(09606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}